Evive Biopharmaceutical (Beijing), Ltd.
FDA inspection history in Beijing, China, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Beijing, China.
Cited most
Across all Evive Biopharmaceutical (Beijing) observations on file
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.142Warehousing procedures1
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.192Production record review1
The complete Evive Biopharmaceutical (Beijing) file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Beijing, China
One Form 483 · 2023 · 7 observations
Latest: Form 483, Jun 7, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-06-07 | 483 Form 483 | Beijing, China | 7 | $99 |
FEI number 3013430082 · most recent document Jun 7, 2023
About Evive Biopharmaceutical (Beijing), Ltd.
How many FDA Form 483s has Evive Biopharmaceutical (Beijing), Ltd. received?
FDA Intel has 1 Form 483 on file for Evive Biopharmaceutical (Beijing), Ltd.; the most recent is dated Jun 7, 2023.
When was Evive Biopharmaceutical (Beijing), Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Evive Biopharmaceutical (Beijing), Ltd. is a Form 483 dated Jun 7, 2023, for the site in Beijing, China.
What did FDA cite at Evive Biopharmaceutical (Beijing), Ltd.?
The regulations cited most in the observations on file for Evive Biopharmaceutical (Beijing), Ltd. are 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.142 (Warehousing procedures), 1 time.